Following a press release on the article by FASEB Mark has been interviewed by a number of publications including Newsweek, The US News and the Daily Mail.
“There is no high-quality data showing that taking the anti-malarial drugs hydroxychloroquine and chloroquine can help COVID-19 patients, the authors of a review of existing evidence have warned. As such, they said the drugs should only be used to treat patients taking part in carefully designed clinical trials.”
